Website
http://dataportal.arc.gov.au/NCGP/API/grants/DP230102313
Funding Status
Active
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
A next-generation whole parasite bovine Babesia vaccine. . In Australia, Babesia parasites cause most of the severe and often fatal cases of cattle-tick fever, a globally significant tick-borne disease. It can be prevented by a live-attenuated parasite vaccine which has critical limitations of a 4-day shelf-life and risk of severe disease if administered to adult cattle. This project aims to evaluate in cattle a novel whole parasite Babesia bovis vaccine that cannot cause disease and can be preserved as an off-the-shelf product without losing efficacy. The expected outcome is a significantly improved vaccine for a major infectious disease that affects primary food production. As the disease imposes a major economic burden, it will have great benefit for the Australian livestock industry.Funded Activity Details
Start Date: 2023
End Date: 12-2024
Funding Scheme: Discovery Projects
Funding Amount: $602,170.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Infectious agents | Veterinary parasitology | Animal production | Animal protection (incl. pests and pathogens) |
ANZSRC Socio-Economic Objective (SEO)
